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Abstract  
AIM: To study the protective effect of medicines on the formation of atherosclerosis in mice, it is needed to 
conduct the study in mice which is not genetically diabetic mice induced by streptozotocin (STZ) to produce 
hyperglycemia and atherosclerosis, compared with mice treated by yolk or its combination. 
MATERIAL AND METHODS: Fifty-six mice, Double Deutch Webster strain, male, receive  10 weeks, 20 - 30 gr 
bodyweight were divided into 4 groups (n = 14) i.e. control (do not received any agents), STZ (45 mg/kg/BW was 
injected intraperitoneally for 5 days), yolk (0.2 cc orally daily for 6 weeks), and combination of STZ and yolk (STZ: 
45 mg/kg/BW intraperitoneally add 0.2 cc yolk orally). All animals were executed in the 42nd day. Then, the aorta 
of the mice’s heart tissue was histopathology examined. Blood glucose and cholesterol levels were determined 
every week. 
RESULTS: Hyperglycemia occurred in mice induced by STZ injection with the highest BGL (521.8 ± 48.2 mg/dl; 
188.4%) in the 4th-week observation; after that BGL decrease.  We found that, except the control, all treatment 
groups with STZ, egg yolk, and combination underwent atherosclerosis. 
CONCLUSION: The present study was able to demonstrate the occurrence of atherosclerosis in mice treated by 
STZ accompanied with increasing blood glucose and cholesterol level. 
 
 
 
 
Introduction 
 
Diabetes mellitus is a chronic metabolic 
disorder, identified by the increase in blood glucose 
level (BGL, hyperglycemia) [1]. Chronic 
hyperglycemia is the initial cause of microvascular 
complication, such as retinopathy, neuropathy and 
nephropathy, as well as macrovascular complications, 
especially cardiomyopathy [2]. The atherosclerosis 
risk factors, explain just of a minor part of the excess 
incidence of vascular disease among diabetic 
patients, diabetogenic factors themselves must 
contribute to the development the arterial disease. In 
particular, hyperglycemia, the primary clinical 
manifestation of diabetes, is thought to contribute, to 
diabetic complication by altering vascular cellular 
metabolism, vascular matrix molecules, and 
circulating lipoproteins. For instance, hyperglycemia 
increases diacylglycerol levels and activates protein 
kinase C activity in the aorta of streptozotocin (STZ) 
induced diabetic rats and dogs [2]. Thickening of the 
basement membranes in renal glomeruli and 
peripheral capillaries has been observed in STZ -
induced diabetic rats and diabetic patients [3].  
Hyperlipidemia is a feature of drug-induced 
diabetes in rats and rabbits, as well as poorly 
controlled diabetes in humans. Alterations in 
lipoprotein–cell interactions are also seen in vitro upon 
glycation of circulating lipoproteins. The role of each 
of these mechanisms in the pathogenesis of macro - 
and microangiopathy needs to be clarified [2] [3]. The 
data from the World Health Organization in 2004 
showed that 30% of mortality rate was caused by 
heart and blood vessel diseases, and 60% of that 
percentage was caused by coronary heart disease [4]. 
In Indonesia, the mortality rate caused by coronary 
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heart disease has increased significantly: from 16% 
(in 1986) to 26.4% (in 2001) and then up to 59.5% (in 
2007) [4][5][6]. This has highlighted the importance 
and urgency of studying the mechanism of diabetic 
atherosclerosis and exploring therapeutic options 
[5][7][8].  
Due to its unique advantages over other 
animal models, the mouse is the most used model for 
studying the mechanism of diabetes-accelerated 
atherosclerosis and exploring effective therapeutic 
approaches. Their advantages are a small size, short 
generation time, and ease of induction of diabetes and 
atherosclerosis by diet, drug treatment (streptozotocin 
or alloxan) or a genetic approach and cost-
effectiveness. In the past decade, several diabetic 
atherosclerosis mouse models have been established 
[7].  
Because in Indonesia it is difficult to obtain 
transgenic mice, the present study focused on to 
make healthy mice become diabetes by injecting STZ. 
Kunjathoor et al., (1996) had shown accelerated 
atherosclerosis in response to hyperglycemia in STZ - 
induced diabetic mice [3]. Kostogrys et al. (2012) 
found that the blood cholesterol level (BCL) was 
significantly increased in egg yolk diet mice and 
promoted atherosclerosis [9].  
Prior studies have found a positive 
relationship hypercholesterolemia in STZ - induced 
diabetic rats as a result from increased intestinal 
absorption and synthesis of cholesterol.
 
This was 
followed by the formation of atherosclerosis, which 
resembles that occurs after high cholesterol diet (egg 
yolk diet) [10][11]. Canadian experts had been 
suspicious of the involvement of egg yolk in 
atherosclerosis formation and then warned people not 
to consume egg yolk [12]. On the contrary, Voutilainen 
et al., found that egg consumption was not associated 
with increased risk of myocardial infarct, where the 
relative risk (RR = 0.87 (95% CI 0.71 - 1.07, p = 0.73) 
in the highest (> 46 g/day) vs the lowest (< 15 g/day) 
cholesterol diet [13].  
Various studies have been conducted to 
prevent and treat diabetic atherosclerosis by using 
antioxidants [14][15][6] and angiotensin receptor 
blockers [18][19][20].  
Therefore, prior to conducting a study on the 
benefits of natural materials, such as caffeic acid 
phenethyl ester (CAPE) and other antioxidants in 
preventing and treating the formation of 
atherosclerosis, it is necessary to conduct a study on 
the effect of STZ injection in mice on the incidence of 
hyperglycemia, hypercholesterolemia, and 
atherosclerosis formation compared to that occurs in 
mice ingested with egg yolk or its combination. 
 
 
 
Material and Methods 
 
Fifty-six male mice (Mus musculus) of 
certified Double Dutch Webster lineage, 8 to 10 weeks 
old, and 20 - 30 gram of body weight were used. 
Before conducting the study, they were adapted to a 
place with light controlling of 12 hour - daylight (6:00 
A.M. – 6:00 P.M.) and 12 dark hours (6:00 P.M. – 6:00 
A.M.) with standard diet (eat and drink ad libitum). 
Their food came from Chroen Phosphate. The mice 
were placed in the natural temperature and humidity 
for 6 weeks. They were weighed once in a week to 
avoid stress. The study began after approved by the 
Committee of Research Ethics of the Faculty of 
Mathematics and Science University of Sumatera 
Utara Medan.  
After an adaptation period, the mice were 
randomly divided into four groups with each group 
consisted of 14 mice. Group I did not get any 
treatment as the control, group II obtained STZ 
injection (45 mg/kg weight, intraperitoneal for five 
days), group III obtained egg yolk (0.2 cc per - oral for 
six weeks), and group IV obtained the combination of 
STZ injection (45 mg/kg weight, intra-peritoneal for 
five days) and egg yolk (0.2 cc per-oral for six weeks). 
STZ was obtained from Nicalai - Japan (Batch no. 
32238 – 91/2). 
 
Laboratory Analysis 
The execution was performed each week by 
cervical dislocation in each group which consisted of 
two mice until the end of the study (six weeks). The 
mice’s tails were cut off each week to get their blood 
for examining glucose level by using digital 
glucometer (Accu-check® Advantage, Roche 
Diagnostic, Germany) and for cholesterol level by 
using digital cholesterol test (Easy touch®GCU, 
Taiwan). The incidence and the severity level of 
atherosclerosis were proved by examining its result, 
using lighting microscope with the magnification of 40-
400 times. The parameter was the thickness of aorta 
wall, the present of foam cells and sclerosis in mice’s 
aorta tissues. The severity of atherosclerosis was 
differentiated into four groups according to 
histopathology findings (Figure 1): 
1. Normal, when the following pathological 
matters were not found; 
2. Mild, when monocyte adherent, foam cells, 
lipid core, proliferation of smooth muscle cells were 
found;  
3. Moderate, when the above matters were 
found plus fibrous plague, sclerosis, and fibrous cap; 
4. Severe, when all the matters above were 
found, followed by rupture and thrombus.  
All data were presented in the Mean ± SEM. 
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The difference of the average of Blood Glucose Level 
(BGL) and Blood Cholesterol Level (BCL) was 
analysed with ANOVA, followed by a post-hoc 
Bonferroni multiple comparisons, correlation of BGL 
and CBL with Pearson’s regression, and the 
difference of the incidence of atherosclerosis among 
the groups with 
2
 test. While for data not normally 
distributed were analysed by Kruskal Wallis. A 
difference or correlation was stated significant when p 
< 0.05. 
 
 
Results 
 
In this present study, the change in the BGL 
(Table 1), BCL (Table 2), and the incidence of 
atherosclerosis (Table 3) were documented.  
Table 1: The profile of blood glucose level (BGL mg/dl; mean ± 
SEM) of all treatment groups, related to time (week) 
 
Groups 
Week (wk)  
0 
N =14 
1 
N = 12 
2 
N = 10 
3 
N = 8 
4 
N = 6 
5 
N = 4 
6 
N = 2 
P 
(Sig) 
Control 157.1 ± 
10.2 
148.1 ± 
6.9 
151.6 ± 
9.6 
144.3 ± 
7.5 
149.2 ± 
9.3 
146.0 ± 
11.25 
192.0 ± 
15.0 
0.515 
STZ  180.7 ± 
7.2 
192.3 ± 
13.5 
258.2 ± 
41.3 
302.8 ± 
47,2 
521.8 ± 
48.2 
310.0 ± 
86.4 
** 0.000 
Egg Yolk  174.9 ± 
7.5 
156.0 ± 
4.2 
164.2 ± 
8.7 
145.9 ± 
4.9 
146.0 ± 
14.3 
145.0 ± 
14.0 
145.0 ± 
5.0 
0.000 
Combination  167.3 ± 
6.5 
181.5 ± 
18.5 
277.2 ± 
39.2 
294.3 ± 
73.9 
392.3 ± 
119.9 
367.0 ± 
108.3 
190.5 ± 
1.5 
0.014 
P  0.123* 0.096 0.006 0.001 0.000 0.115 0.291  
*Kruskal Wallis; ** death mice. 
 
Table 1 showed no significant change of BGL 
in control group until the 5
th
 week, except in the last 
week (in the 6
th
 week BGL is 192.0 ± 15.0 mg/dl), 
BGL slightly increased (22.3%). In the STZ group, 
BGL increased significantly (188.4%) in the 4
th
 week; 
it then decreased after the 4
th
 week, and before the 6
th
 
week (the 39
th
 day) the mice died before the 
execution. In the groups where the mice obtained egg 
yolk, BGL significantly decreases to 17.1% until the 
end of the study. As demonstrated in STZ group, in 
the combination group, BGL increased to 134.7% until 
the 4
th
 week, and it then decreased again by the end 
of the study, this BGL alteration is statistically 
significant.  
 Table 1 also showed the difference of BGL 
among the groups, related to time, where significant 
difference started from the 2
nd
 week up to the end of 
the study. The most significant difference of BGL was 
found in the 4
th
 week. However, the difference 
between BGL in STZ group and the combination 
group was not statistically significant in all observed 
weeks.  
Table 2 showed that the average of BCL in all 
treatment groups tended to increase, including in the 
control groups. In the control group, BCL increased 
from 150.2 ± 15.5 mg/dl in the 1
st
 week to 216.0 ± 
37.0 mg/dl in the 6
th
 week, where the highest CBL in 
the 4
th
 week (227.0 ± 22.7 mg/dl; 33.9%).  
Table 2: The profile of blood cholesterol level (mg/dl; mean ± 
SEM) of all treatment groups, related to time (week) 
 
Groups 
Week (wk) 
0 
N = 14 
1 
N = 12 
2 
N = 10 
3 
N = 8 
4 
N = 6 
5 
N = 4 
6 
N = 2 
     P  
Control 
152.5± 
13.3 
150.2 ± 
15.5 
156.5 ± 
11.6 
178.4 ± 
15.6 
227.0 ± 
22.7 
178.0 ± 
5.7 
216.0 ± 
37.0 
   0.039 
STZ  
120.8± 
6.0 
122.1 ± 
6.8 
148.3 ± 
7.2 
175.5 ± 
17.5 
215.0 ± 
13.8 
 119.8 ± 
8.3 
**    0.000 
Egg Yolk 
139.8± 
7.4 
141.2 ± 
8.5 
151.0 ± 
11.6 
181.1 ± 
9.4 
165.3 ± 
13.7 
 145.0 ± 
21.0 
135.5 ± 
122.5 
    0.289 
Combi-
nation 
168.8± 
12.7 
176.3 ± 
13.5 
152.6 ± 
8.6 
169.8 ± 
13.8 
181.8 ± 
4.7 
 163.3 ± 
23.1 
166.5 ± 
7.5 
    0.895 
P  0.244*  0.188  0.220  0.421  0.461  0.461  0.433   
*, Kruskal Wallis; **, death mice. 
 
In the STZ group, the highest increase of BCL 
(76.2%) occurred in the 4
th
 week; after that, it was 
decreased. The same profile to the egg yolk group 
which the highest increase of BCL (17.9%) was 
occurred in the 4
th
 week, while in the combination 
group, the highest increase of the CBL (6.8%) 
occurred in the 4
th
 week, and after that, it decreased 
lower than the initial level. However, the changes of 
BCL in the yolk and combination groups were not 
significant. Furthermore, based on ANOVA statistical 
analyses there was no significant difference in CBL 
between groups for each weeks observation, with an 
exception for the data of BCL at week-0 was analysed 
by Kruskal Wallis. 
Table 3: The incidence of atherosclerosis 
Severity Control STZ Egg yolk Combination 
Normal 13 0 4 0 
Mild 1 3 4 1 
Moderate 0 11 6 12 
Severe 0 0 0 1 

2
 = 45.05; df = 9; P < 0.0001. 
 
Table 3 showed that the incidence of 
atherosclerosis was statistically different (p < 0.0001). 
Atherosclerosis was hardly found in the control group. 
In the STZ group, all mice underwent atherosclerosis, 
and the most serious incident was found in the 
combination group. In the egg yolk group, some mice 
did not undergo atherosclerosis.  
 
Figure 1: Microscopic Classification of the Atherosclerosis Severity between 
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groups; i.e. Control, STZ, Egg yolk and Combination by magnification 400 
times 
Furthermore, in the present study, there was 
a significant positive correlation (p < 0.05) between 
BGL and CBL in STZ group (r = 0.8469), while in egg 
yolk group there was a significant negative correlation 
(r = -0.8476). On the contrary, there was no significant 
correlation between BGL and BCL in the combination 
group (r = 0.1170). 
 
 
Discussion 
 
The present study was successful in 
demonstrating that hyperglycemia occurred in mice 
induced by STZ injection (Table 1) with the highest 
BGL (521.8 ± 48.2 mg/dl; 188.4%) appeared in the 
4
th
-week observation; after that BGL decrease. 
Unfortunately, before the 6
th
 week (i.e. the 39
th
 day), 
the mice died before the execution. This might be 
probably caused by the inability to consume food and 
drink by them. The condition of dehydration 
accompanied by high BGL in mice may lead to the 
occurrence of ketoacidosis followed by death [21]. 
 
In the present study, we used STZ (45 mg/kg 
BW intraperitoneally for 5 consecutive days) to induce 
diabetes in mice. Streptozotocin enters the pancreatic 
cell via a glucose transporter - GLUT2 and causes 
alkylation acid and then destruct DNA [22]. Twenty 
years ago, Kunjathoor et al. (1996) have 
demonstrated that injection of STZ (40 mg/kg BW 
intraperitoneally for 5 consecutive days) in mice may 
increase BGL (250 -420 mg/dl), as the result of the 
decrease in plasma insulin level [3]. Arora et al. 
(2009) demonstrated that single injection of 180 
mg/kg BW STZ will induce diabetes type 1 mice, and 
100 mg/kg bw failed to produce diabetes except for 
sustained hyperglycemia. However, in multiple low 
doses STZ 40 mg/kg, BW for 5 days constitutively will 
induce diabetes type 2 [23]. While Mansor et al. 
(2013) demonstrated that administration STZ 
intraperitoneally in various doses 15, 20, 25 mg/kg 
BW gave no effect on BGL and did not change insulin 
concentration in the rat. In contrast dose of 30 mg/kg, 
BW STZ induced hypoinsulinemia, hyperketonemia 
and weight loss. It appears there is a positive dose-
dependent relationship between the dose of STZ and 
BGL [24]. 
In the control group, there was no significant 
change of BGL, except in the last week of the study 
(the 6
th
 week) there was a slight increase of the BGL 
(22.3%). The similar profile of the BGL happened in 
the egg yolk group, but BGL tends to decrease lower 
than the initial BGL (17.1%) at the end of the study. 
Jung et al. have given fatty diet to mice and found that 
BGL, BCL and insulin increased [8]. Theoretically, an 
increase of insulin level should be followed by the 
decrease in BGL. Although our study did not examine 
insulin level, the report of Jung et al. could explain 
why in the present study the decrease of BGL was 
found in the egg yolk group as the result of the 
increase of insulin secretion. [8]. As happened in the 
STZ group and combination group there was a 
significant increase of BGL (134,7%) in the 4
th
 week, 
after that BGL decrease although still higher than 
basal level (13.8%) at the end of the study. 
There was a contradictory of the highest 
percentage increase of BGL at the 4
th
 week of STZ 
group (188.4%) and combination group (134.7%), the 
effect of the increasing BGL by STZ was hampered by 
egg yolk which decreased BGL. Mansor et al. (2013) 
demonstrated that high-fat diet or in combination with 
STZ did not increase BGL. High cholesterol diets 
produce hyperinsulinemia mice [24].
 
A combination of 
various doses of STZ (15, 20, 25 and 30 mg/kg/BW) 
with high - fat diet, demonstrated that combination of 
25 mg/kg STZ was able to rise in BGL [25].  
The present study demonstrated that the BCL 
tended to increase, related to time, in all treatment 
groups, including the control group. In the control 
group, BCL increased up to 33.9%, while in the STZ 
and egg yolk group the increase in of BCL was twice 
as much as that in the control group. The BCL 
increased up to 76.2% in the STZ group was occurred 
in the 4
th
 week; after that, BCL decreased. In the egg 
yolk group, the highest BCL of 70.9% occurred in the 
6
th
 week. Unfortunately, the alteration of BCL was not 
statically significant. On the contrary in the 
combination group there was a slight increase of BCL 
(2.8%), and at the last week, BCL decreases lower 
than initial level. This data demonstrated that egg yolk 
diet has minimal effect on BGL although co-
administration with STZ. The mechanism of negative 
interaction should be investigated.  
Spence et al. found a significant difference of 
the area of atherosclerosis plague (p < 0.0001) in 
patients who consumed a different amount of egg 
yolk. People who consume fewer than two eggs a 
week (125 ± 129 mm
2
) will have a smaller area than 
those who consumed three eggs or more a week (132 
± 142 mm
2
) [12]. They recommended that the patients 
with the risk for cardiovascular disease do not 
consume egg yolk continuously. Consuming 
cholesterol-rich diet should be consumed less than 
200 mg per day while egg yolk of a big egg contains 
about 275 mg cholesterol which is more than daily 
need. From the study on the animal experiment, it was 
found that cholesterol-rich diet will weigh down the 
accumulation of macrophage in adipose and 
atherosclerosis tissues in mice and increase systemic 
inflammation [12]. 
Although egg yolk was rich in cholesterol, 
consuming it in some subjects did not have any effect 
on BCL. Nevertheless, oxidised cholesterol could 
increase atherosclerosis although BCL was normal. 
Oxidized LDL plays an important role in initiation and 
progress of atherosclerosis. Meanwhile, a Finland 
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researcher reported that consuming egg yolk regularly 
would not affect the area of carotid plague or acute 
myocardium infarct in Finland males [13]. 
Even though the previous investigators gave 
controversial information, the finding in the present 
study showed that, except the control, all treatment 
groups with STZ, egg yolk, and combination 
underwent atherosclerosis. The incidence of 
atherosclerosis was hardly found in the control group 
although one mouse was executed in week 0. This 
incidence might be probably caused by a genetic 
factor. In the STZ group, all mice underwent 
atherosclerosis in which the most serious incidence 
was found in the combination group of STZ and egg 
yolk. In the egg yolk group, there were some mice 
which did not undergo atherosclerosis; they were 
executed in week 0 and the 1
st
 week. The combination 
of STZ and egg yolk cholesterol-rich diet gave 
synergic effect in forming atherosclerosis. Chono et al. 
had researched the benefit of an anti-atherosclerotic 
medicine which was tested on atherogenic mice, not 
on usual mice. In fact, Chono study took longer time 
(14 weeks) to form atherosclerosis after cholesterol-
rich diet
25 
compared with the findings in the present 
study (4 weeks) [25].  
This present study showed significant positive 
between BGL and BCL in the STZ group at R-value = 
0.8469 which indicated the increasing of BGLwill 
followed by the increase in blood cholesterol level. 
However, in the egg yolk group, there was a negative 
correlation at R-value = -0.8476 in which BGL 
decreased will follow by the increase in BCL. On the 
contrary, there was no significant correlation between 
BGL and BCL in the combination group (r = 0.1170).  
Based on the data obtained in the present 
study, the next study of the benefit of antioxidant 
CAPE and angiotensin receptor blocker telmisartan on 
the incidence of atherosclerosis in diabetic mice 
induce by STZ could be conducted for 4 week 
observation. In the 4
th
 week treatment, there was a 
significant change in histopathology (atherosclerosis) 
and laboratories (hyperglycemia, and 
hypercholesterolemia) after giving of STZ to non-
transgenic mice. 
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